Maximising Generic Utilisation: The Power of Pharmacy Benefit Management

Snow, David B.

doi:10.1057/palgrave.jgm.4950095

Cited by 7 publications

(4 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For prescription as well as patients benefit plans, generics are one of the best options available in today's healthcare market. They offer the therapeutic benefits of their brand-name counterparts for only a fraction of the cost, providing more affordable access to pharmaceutical care (Snow, 2007).…”

Section: Generic Drugs Definedmentioning

confidence: 99%

The effect of country of origin on brand equity: an empirical study on generic drugs

Sanyal¹,

Datta

2011

Journal of Product &Amp; Brand Management

View full text Add to dashboard Cite

Purpose -The purpose of this paper is to explore the impact of country of origin image on brand equity of branded generic drugs. Design/methodology/approach -Brand equity of branded generics is examined through an analytical review. Country of origin image is hypothesised to influence components of brand equity, i.e. brand strength and brand awareness, which in turn influence brand equity. An empirical investigation was carried out among professionally similar respondents, i.e. doctors of different categories in Kolkata megapolis, India. Findings -Results showed that country of origin image had a positive and significant effect on components of brand equity, i.e. brand strength and brand awareness, derived from factor analysis conducted on brand equity components. The result also showed that country of origin image of branded generics significantly, but indirectly, affected brand equity through the mediating variables, brand strength and brand awareness. Research limitations/implications -Different variables have influence on brand equity. This study dealt with only one type of variable, i.e. country of origin image, that may limit the total process of brand equity enhancement. Practical implications -Marketing actions should be implemented to enhance brand strength and awareness levels. Country of origin image should be assessed as a multidimensional concept for enhancing brand equity. Marketers should be aware of the fact that physicians are influenced by the brand's original country image. Originality/value -This research work has extended prior country of origin research by conceptualising the country of origin image as a brand equity enhancing tool in a new area called branded generic drugs.

show abstract

Section: Generic Drugs Definedmentioning

confidence: 99%

The effect of country of origin on brand equity: an empirical study on generic drugs

Sanyal¹,

Datta

2011

Journal of Product &Amp; Brand Management

View full text Add to dashboard Cite

show abstract

“…Jedes Arzneimittel ist mittlerweile nicht nur durch ein einziges, sondern im Schnitt durch zehn Patente geschützt [1], es kommt zu zunehmenden gerichtlichen Auseinandersetzungen über Patentverletzungen, aber auch zu Verträgen über "authorisierte" Generika und Generikaproduktion sowie "line extensions" durch "big pharma" selbst [1,4,5]. Die Grenzen zwischen "forschenden" Unternehmen und "Generikafirmen" sind somit etwas unschärfer geworden.…”

Section: Generika In öSterreich 2003-2008: Ein Updateunclassified

“…Der Generikamarkt ist ein Wachstumsmarkt geworden und wird es wohl auf absehbare Zeit bleiben. Im Laufe der nächsten 5 Jahre werden etwa 100 Arzneimittel patentfrei werden und somit Arzneimittelumsätze von etwa 50 Milliarden US $ (in den USA) "generikafähig" werden [4,5]. Darüberhinaus werden in den nächsten Jahren auch eine Reihe von "Biologika" [6] patentfrei, was nach der Zulassung erster "Biosimilars", wie z.B.…”

unclassified

Generika in Österreich 2003–2008: ein Update

Müller

2008

Wien Klin Wochenschr

View full text Add to dashboard Cite

“…The growing availability and the rapid use of first time generic drugs have an impact on prescription drug expenditures (Hoffman et al , 2009). By 2007, generic drugs globally accounted for almost 60 per cent of prescription drugs dispensed (Snow, 2007). This generic market growth will not decline in the near future as over $15 billion in sales of brand‐name drugs is expected to be lost to generic drugs in 2011 and 2012 (Hoffman et al , 2009).…”

Section: Introductionmentioning

confidence: 99%

Practice on generic medicine recommendation and dispensing among Jordanian pharmacists

Riquelme¹,

Elthani²,

Rios

2011

Journal of Islamic Marketing

View full text Add to dashboard Cite

If you would like to write for this, or any other Emerald publication, then please use our Emerald for Authors service information about how to choose which publication to write for and submission guidelines are available for all. Please visit www.emeraldinsight.com/authors for more information. About Emerald www.emeraldinsight.comEmerald is a global publisher linking research and practice to the benefit of society. The company manages a portfolio of more than 290 journals and over 2,350 books and book series volumes, as well as providing an extensive range of online products and additional customer resources and services.Emerald is both COUNTER 4 and TRANSFER compliant. The organization is a partner of the Committee on Publication Ethics (COPE) and also works with Portico and the LOCKSS initiative for digital archive preservation. AbstractPurpose -The purpose of this paper is to investigate the percentage of generic inventory pharmacists have in stock, to comprehend why pharmacists in Jordan recommend and dispense generic products. Design/methodology/approach -In total, 104 pharmacists were surveyed using a structured questionnaire. The questionnaire contained statements about perception of generic products, inclination to recommend generic products, importance of promotions, factors influencing a recommendation, stock of generics, and among others. Correlational and discriminant analyses were used to establish associations between variables to distinguish characteristics between groups. Findings -More than half of the Jordanian pharmacists sampled carry between 20 and 39 per cent stock of generic drugs and 46 per cent carry more than 40 per cent stock. One-third (33 per cent) substitutes branded products by generic ones and slightly more (36 per cent) recommend more generic than branded products as opposed to those who recommend more branded products (24 per cent). Male pharmacists (49 per cent) tend to recommend more generic products than do females (24.6 per cent) and those who recommend more branded products are more influenced by sales visits rather than manufacturer's name or bonuses. Originality/value -The paper provides valuable information about the pharmaceutical industry in Jordan and the empirical study adds insights from pharmacists about generic medicine.

show abstract

Maximising Generic Utilisation: The Power of Pharmacy Benefit Management

Cited by 7 publications

References 2 publications

The effect of country of origin on brand equity: an empirical study on generic drugs

The effect of country of origin on brand equity: an empirical study on generic drugs

Generika in Österreich 2003–2008: ein Update

Practice on generic medicine recommendation and dispensing among Jordanian pharmacists

Contact Info

Product

Resources

About